Corient Private Wealth
XRAY icon

Corient Private Wealth’s Dentsply Sirona XRAY Stock Holding History

Corient Private Wealth’s Portfolio XRAY Stock Details XRAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$208K Sell
19,636
-15,504
-44% -$169K ﹤0.01% 2784
2026
Q1 		$395K Buy
35,140
+9,941
+39% +$124K ﹤0.01% 2155
2025
Q4 		$288K Sell
25,199
-3,973
-14% -$46.6K ﹤0.01% 2196
2025
Q3 		$370K Sell
29,172
-2,083
-7% -$30.2K ﹤0.01% 1989
2025
Q2 		$487K Buy
+31,255
New +$467K ﹤0.01% 1719
2024
Q4 		– Sell
-13,616
Closed -$368K – 2559
2024
Q3 		$368K Buy
13,616
+4,663
+52% +$119K ﹤0.01% 1912
2024
Q2 		$223K Sell
8,953
-4,843
-35% -$139K ﹤0.01% 2071
2024
Q1 		$458K Buy
13,796
+2,365
+21% +$80.8K ﹤0.01% 1679
2023
Q4 		$407K Buy
11,431
+1,789
+19% +$56.8K ﹤0.01% 1717
2023
Q3 		$329K Sell
9,642
-381
-4% -$14.5K ﹤0.01% 1712
2023
Q2 		$401K Buy
10,023
+754
+8% +$30K ﹤0.01% 1559
2023
Q1 		$364K Buy
+9,269
New +$340K ﹤0.01% 1513

Other funds holding XRAY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
SCA
Southpoint Capital Advisors New York $4.4B AUM 49.36% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

Corient Private Wealth's XRAY Position: Q2 2026 in Review

Corient Private Wealth reduced its Dentsply Sirona (XRAY) stake by 44% in Q2 2026, selling an estimated $169K and leaving 19,636 shares worth $208K. The position accounts for ﹤0.01% of the portfolio, ranked #2784.

Corient Private Wealth first reported a position in XRAY in Q1 2023 and has held it in 12 quarters since. The position peaked at $487K in Q2 2025. 373 funds tracked by Wall St. Rank hold XRAY as of Q2 2026.

  • Corient Private Wealth held 19,636 shares of Dentsply Sirona worth $208K as of Q2 2026.
  • Corient Private Wealth sold 15,504 Dentsply Sirona shares in Q2 2026, an estimated $169K.
  • Dentsply Sirona made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #2784 holding.
  • Corient Private Wealth first reported a position in Dentsply Sirona in Q1 2023 and has held it in 12 quarters since.
  • Corient Private Wealth's Dentsply Sirona position peaked at $487K in Q2 2025.
  • 373 funds tracked by Wall St. Rank held Dentsply Sirona as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.